Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma.

Mutter RW, Lok BH, Dutta PR, Riaz N, Setton J, Berry SL, Goenka A, Zhang Z, Rao SS, Wolden SL, Lee NY.

Radiat Oncol. 2013 Jul 9;8:173. doi: 10.1186/1748-717X-8-173.

2.

Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.

Truong MT, Romesser PB, Qureshi MM, Kovalchuk N, Orlina L, Willins J.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):158-64. doi: 10.1016/j.ijrobp.2011.10.079. Epub 2012 Jan 31.

3.

Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.

Thomas TO, Refaat T, Choi M, Bacchus I, Sachdev S, Rademaker AW, Sathiaseelan V, Karagianis A, Mittal BB.

Radiat Oncol. 2015 Apr 18;10:94. doi: 10.1186/s13014-015-0409-5.

4.

Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.

Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):771-7. doi: 10.1016/j.ijrobp.2013.11.244.

PMID:
24606846
5.

Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.

Amini A, Yang J, Williamson R, McBurney ML, Erasmus J Jr, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e391-8. doi: 10.1016/j.ijrobp.2011.06.1961.

6.

Dosimetric benefits of placing dose constraints on the brachial plexus in patients with nasopharyngeal carcinoma receiving intensity-modulated radiation therapy: a comparative study.

Jiang H, Lu H, Yuan H, Huang H, Wei Y, Zhang Y, Liu X.

J Radiat Res. 2015 Jan;56(1):114-21. doi: 10.1093/jrr/rru072. Epub 2014 Aug 30.

7.

Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.

Refaat T, Choi M, Thomas TO, Bacchus I, Agulnik M, Pelzer HJ, Mellott AL, Rademaker AW, Liu D, Sathiaseelan V, Mittal BB.

Am J Clin Oncol. 2015 Dec;38(6):588-94. doi: 10.1097/COC.0000000000000001.

8.

Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer.

Chen AM, Hall WH, Li J, Beckett L, Farwell DG, Lau DH, Purdy JA.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):165-9. doi: 10.1016/j.ijrobp.2011.11.019. Epub 2012 Mar 22.

PMID:
22444998
9.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
10.

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):363-73. Epub 2005 May 31.

PMID:
15925451
11.

A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.

Lohia S, Rajapurkar M, Nguyen SA, Sharma AK, Gillespie MB, Day TA.

JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):331-7. doi: 10.1001/jamaoto.2013.6777.

PMID:
24557509
12.

Dose-volume modeling of brachial plexus-associated neuropathy after radiation therapy for head and neck cancer: in regard to Chen et al.

Beitler JJ, Jegadeesh NK, Higgins K.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):474-5. doi: 10.1016/j.ijrobp.2014.06.027. No abstract available.

PMID:
25304808
13.

Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.

Eblan MJ, Corradetti MN, Lukens JN, Xanthopoulos E, Mitra N, Christodouleas JP, Grover S, Fernandes AT, Langer CJ, Evans TL, Stevenson J, Rengan R, Apisarnthanarax S.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):175-81. doi: 10.1016/j.ijrobp.2012.03.051. Epub 2012 Jun 1.

PMID:
22658442
14.

[Constraints of the dentist are consistent with the results of an optimal irradiation with modulated intensity in N0 oropharyngeal cancer].

Jaussaud S, Guihard S, Niederst C, Borel C, Meyer P, Hémar P, Schultz P, Noël G, Féki A.

Cancer Radiother. 2013 Jul-Aug;17(4):265-71. doi: 10.1016/j.canrad.2013.01.020. Epub 2013 May 29. French.

PMID:
23726044
15.

Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.

Yi SK, Hall WH, Mathai M, Dublin AB, Gupta V, Purdy JA, Chen AM.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1060-4. doi: 10.1016/j.ijrobp.2010.10.035. Epub 2011 Apr 30.

PMID:
21536393
16.

Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.

Forquer JA, Fakiris AJ, Timmerman RD, Lo SS, Perkins SM, McGarry RC, Johnstone PA.

Radiother Oncol. 2009 Dec;93(3):408-13. doi: 10.1016/j.radonc.2009.04.018. Epub 2009 May 18.

PMID:
19454366
17.

Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.

Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP, Upreti RR, Budrukkar A, Murthy V, Deshpande DD, Shrivastava SK, Dinshaw KA, Cozzi L.

Radiother Oncol. 2009 Jul;92(1):111-7. doi: 10.1016/j.radonc.2008.12.008. Epub 2009 Jan 20.

PMID:
19157609
18.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
19.

Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.

Claus F, Duthoy W, Boterberg T, De Gersem W, Huys J, Vermeersch H, De Neve W.

Oral Oncol. 2002 Sep;38(6):597-604.

PMID:
12167438
20.

Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.

Loo SW, Geropantas K, Wilson P, Martin WM, Roques TW.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):162-70. doi: 10.1016/j.clon.2012.07.015. Epub 2012 Aug 18.

PMID:
22906546

Supplemental Content

Support Center